Additional adjuvant radiotherapy improves survival at 1 year after surgical treatment for pancreatic cancer patients with T4, N2 disease, positive resection margin, and receiving adjuvant chemotherapy

Additional adjuvant radiotherapy improves survival at 1 year after surgical treatment for pancreatic cancer patients with T4, N2 disease, positive resection margin, and receiving adjuvant chemotherapy

BackgroundWhile adjuvant chemotherapy has been established as standard practice following radical resection of pancreatic ductal adenocarcinoma (PDAC), the role of adjuvant radiation therapy (RT) and which patients may benefit remains unclear.MethodsThis retrospective study included PDAC patients wh...

Full description

Bibliographic Details
Main Authors: Lili Wu, Yaolin Xu, Yuhong Zhou, Zhaochong Zeng, Yue Fan, Dansong Wang, Wenchuan Wu, Xi Guo, Minzhi Lv, Yuxiu Ouyang, Shisuo Du, Wenhui Lou
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-07-01
Series:Frontiers in Oncology
Subjects:
pancreatic ductal adenocarcinoma
radiotherapy
chemotherapy
surgery
overall survival
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1109068/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2023.1109068/full

Similar Items